| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 17 May 2025 | 18 Sep 2025 | 18 Sep 2025 | 0.5 | 5 | Final |
| The Board has recommended Dividend of Rs. 0.50 (Fifty paise only) per Equity Share of face value of Rs. 10/- (Rupees Ten only) each fully paid up for the Financial Year 2024-25, subject to the approval by shareholders of the Company at the ensuing Annual General Meeting (AGM). Remus Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Sep-2025. (As Per NSE Announcement Dated On : 02.09.2025) | ||||||
| Dividend | 9 Nov 2024 | 19 Nov 2024 | 20 Nov 2024 | 1 | 10 | Interim |
| Interim Dividend for FY 2024-25 of 10% i.e., Re. 1.00 per equity share of face value of Rs. 10.00 each. The record date for the purpose of payment of Interim Dividend, as intimated earlier will be November 20, 2024 | ||||||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.